2015
Synthesis and anticancer activity of novel fused pyrimidine hybrids of myrrhanone C, a bicyclic triterpene of Commiphora mukul gum resin
Mallavadhani, U., Madasu, C., Nayak, L., & Ramakrishna, S. (2015). Synthesis and anticancer activity of novel fused pyrimidine hybrids of myrrhanone C, a bicyclic triterpene of Commiphora mukul gum resin. 19(4).
The Benefits of Faculty Development Span Far Beyond Teaching Skills.
Campbell, P. (2015). The Benefits of Faculty Development Span Far Beyond Teaching Skills. 79(7). https://doi.org/10.5688/ajpe797108
The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin.
Lu, J., Liu, P., Wang, L., Ghazwani, M., Xu, Y.- ming, Huang, P.-L., Ma, C., Zhang, D., & Li, X. (2015). The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin. 62. https://doi.org/10.1016/j.biomaterials.2015.05.046
Thermosensitive Gel Containing Cellulose Acetate Phthalate-Efavirenz Combination Nanoparticles for Prevention of HIV-1 Infection.
Date, A., Shibata, A., McMullen, E., La Bruzzo, K., Bruck, P., Belshan, M., Zhou, L., & Destache, C. (2015). Thermosensitive Gel Containing Cellulose Acetate Phthalate-Efavirenz Combination Nanoparticles for Prevention of HIV-1 Infection. 11(3). https://doi.org/10.1166/jbn.2015.1942
Using learning theory, interprofessional facilitation competencies, and behavioral indicators to evaluate facilitator training.
LeGros, T., Amerongen, H., Cooley, J., & Schloss, E. (2015). Using learning theory, interprofessional facilitation competencies, and behavioral indicators to evaluate facilitator training. 29(6). https://doi.org/10.3109/13561820.2015.1040874
2014
A pharmaceutical industry elective course on practice experience selection and fellowship pursuit by pharmacy students.
Hartman, C., Blustein, L., Morel, D., & Davis, L. (2014). A pharmaceutical industry elective course on practice experience selection and fellowship pursuit by pharmacy students. 78(6). https://doi.org/10.5688/ajpe786126
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme.
Rosenfeld, M., Ye, Y., Supko, J., Desideri, S., Grossman, S., Brem, S., Mikkelson, T., Wang, L., Chang, C.-Y., Hu, S., McAfee, Q., Fisher, J., Troxel, A., Piao, S., Heitjan, D., Tan, K.-S., Pontiggia, L., O’Dwyer, P., Davis, L., & Amaravadi, R. (2014). A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme. 10(8). https://doi.org/10.4161/auto.28984
An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistance.
Lu, J., Zhao, J., Liu, P., Marquez, R., Huang, P.-L., Zhang, D., Li, X., Xie, C., Venkataramanan, R., Xu, Y.- ming, & Li, X. (2014). An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistance. 196. https://doi.org/10.1016/j.jconrel.2014.10.016
Analysis of the HNO and NO donating properties of alicyclic amine diazeniumdiolates.
Bharadwaj, G., Benini, P., Basudhar, D., Ramos-Colon, C., Johnson, M., Larriva, M., Keefer, L., Andrei, D., & Miranda, K. (2014). Analysis of the HNO and NO donating properties of alicyclic amine diazeniumdiolates. 42. https://doi.org/10.1016/j.niox.2014.08.013
Assessing the effect of providing a pharmacist with patient diagnosis on electronic prescription orders: a pilot study.
Warholak, T., Rupp, M., Leal, S., Kurniawan, G., & Patel, P. (2014). Assessing the effect of providing a pharmacist with patient diagnosis on electronic prescription orders: a pilot study. 10(1). https://doi.org/10.1016/j.sapharm.2013.04.010
Celecoxib nanosuspension: single-step fabrication using a modified nanoprecipitation method and in vivo evaluation.
Malkani, A., Date, A., & Hegde, D. (2014). Celecoxib nanosuspension: single-step fabrication using a modified nanoprecipitation method and in vivo evaluation. 4(4). https://doi.org/10.1007/s13346-014-0201-3
Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma.
Vogl, D., Stadtmauer, E., Tan, K.-S., Heitjan, D., Davis, L., Pontiggia, L., Rangwala, R., Piao, S., Chang, C.-Y., Scott, A., Paul, S., Nichols, W., Porter, N., Kaplan, J., Mallon, G., Bradner, J., & Amaravadi, R. (2014). Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma. 10(8). https://doi.org/10.4161/auto.29264
Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma.
Rangwala, R., Chang, C.-Y., Hu, S., Algazy, K., Evans, P., Fecher, L., Schuchter, L., Torigian, D., Panosian, J., Troxel, A., Tan, K.-S., Heitjan, D., DeMichele, A., Vaughn, D., Redlinger, M., Alavi, A., Kaiser, C., Pontiggia, L., Davis, L., … Amaravadi, R. (2014). Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma. 10(8). https://doi.org/10.4161/auto.29119
Development of a pharmacy capstone course from focus groups to advanced patient care.
Lee, J., Cooley, J., Tanner, N., Hanauer, C., Schiefer, D., & Herrier, R. (2014). Development of a pharmacy capstone course from focus groups to advanced patient care. 78(8). https://doi.org/10.5688/ajpe788156
IMPACT--Integrative Medicine PrimAry Care Trial: protocol for a comparative effectiveness study of the clinical and cost outcomes of an integrative primary care clinic model.
Herman, P., Dodds, S., Logue, M., Abraham, I., Rehfeld, R., Grizzle, A., Urbine, T., Horwitz, R., Crocker, R., & Maizes, V. (2014). IMPACT--Integrative Medicine PrimAry Care Trial: protocol for a comparative effectiveness study of the clinical and cost outcomes of an integrative primary care clinic model. 14. https://doi.org/10.1186/1472-6882-14-132
Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies.
Eedara, B., Veerareddy, P., Jukanti, R., & Bandari, S. (2014). Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies. 40(8). https://doi.org/10.3109/03639045.2013.801984
Mice deficient in intestinal epithelium cytochrome P450 reductase are prone to acute toxin-induced mucosal damage.
Ahlawat, S., Xie, C., Zhu, Z., D’Hondt, R., Ding, X., Zhang, D., & Mantis, N. (2014). Mice deficient in intestinal epithelium cytochrome P450 reductase are prone to acute toxin-induced mucosal damage. 4. https://doi.org/10.1038/srep05551
Molecular characterization of SjBIRP, another apoptosis inhibitor, from Schistosoma japonicum.
Dao, J., Zhu, Z., Luo, G., Hu, S., Wang, L., Li, X., Lu, J., Liu, P., Lin, G., & Cheng, H. (2014). Molecular characterization of SjBIRP, another apoptosis inhibitor, from Schistosoma japonicum. 113(11). https://doi.org/10.1007/s00436-014-4075-6
Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma.
Rangwala, R., Leone, R., Chang, C.-Y., Fecher, L., Schuchter, L., Kramer, S., Tan, K.-S., Heitjan, D., Rodgers, G., Gallagher, M., Piao, S., Troxel, A., Evans, P., DeMichele, A., Nathanson, K., O’Dwyer, P., Kaiser, C., Pontiggia, L., Davis, L., & Amaravadi, R. (2014). Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. 10(8). https://doi.org/10.4161/auto.29118
Regulation of intestinal cytochrome P450 expression by hepatic cytochrome P450: possible involvement of fibroblast growth factor 15 and impact on systemic drug exposure.
Zhu, Z., Ding, X., Fang, D., & Zhang, D. (2014). Regulation of intestinal cytochrome P450 expression by hepatic cytochrome P450: possible involvement of fibroblast growth factor 15 and impact on systemic drug exposure. 85(1). https://doi.org/10.1124/mol.113.088914
Role of hepatic and intestinal p450 enzymes in the metabolic activation of the colon carcinogen azoxymethane in mice.
Megaraj, V., Ding, X., Fang, D., Kovalchuk, N., Zhu, Z., & Zhang, D. (2014). Role of hepatic and intestinal p450 enzymes in the metabolic activation of the colon carcinogen azoxymethane in mice. 27(4). https://doi.org/10.1021/tx4004769
Self-assembled FUS binds active chromatin and regulates gene transcription.
Yang, S., Gal, J., Chen, Q., & Zhu, Z. (2014). Self-assembled FUS binds active chromatin and regulates gene transcription. 111(50). https://doi.org/10.1073/pnas.1414004111
Stable histone adduction by 4-oxo-2-nonenal: a potential link between oxidative stress and epigenetics.
Galligan, J., Rose, K., Beavers, W., Hill, S., Tallman, K., Tansey, W., & Marnett, L. (2014). Stable histone adduction by 4-oxo-2-nonenal: a potential link between oxidative stress and epigenetics. 136(34). https://doi.org/10.1021/ja503604t
Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier.
Lu, J., Zhao, J., Huang, P.-L., Liu, P., Marquez, R., Gibbs, R., Li, X., Venkataramanan, R., Xu, Y.- ming, Li, X., & Li, X. (2014). Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier. 11(11). https://doi.org/10.1021/mp500389v
2013
A cluster randomized trial of an organizational linkage intervention for offenders with substance use disorders: study protocol.
Friedmann, P., Ducharme, L., Welsh, W., Frisman, L., Knight, K., Kinlock, T., Mitchell, J., Hall, E., Urbine, T., Gordon, M., Abdel-Salam, S., O’Connell, D., Albizu-Garcia, C., Knudsen, H., Duval, J., & Fenster, J. (2013). A cluster randomized trial of an organizational linkage intervention for offenders with substance use disorders: study protocol. 1(6). https://doi.org/10.1186/2194-7899-1-6
A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study.
Gesualdo, L., London, G., Turner, M., Lee, J., Macdonald, K., Goldsmith, P., Covic, A., Zaoui, P., Combe, C., Mann, G., Dellanna, F., Muenzberg, M., & Abraham, I. (2013). A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study. 8(5). https://doi.org/10.1007/s11739-011-0622-7
A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.
Date, A., & Destache, C. (2013). A review of nanotechnological approaches for the prophylaxis of HIV/AIDS. 34(26). https://doi.org/10.1016/j.biomaterials.2013.05.012
An interprofessional psychiatric advanced pharmacy practice experience.
Goldstone, L., & Cooley, J. (2013). An interprofessional psychiatric advanced pharmacy practice experience. 77(6). https://doi.org/10.5688/ajpe776129
Antidepressant use and new-onset diabetes: a systematic review and meta-analysis.
Bhattacharjee, S., Bhattacharya, D., Kelley, D., & Sambamoorthi, U. (2013). Antidepressant use and new-onset diabetes: a systematic review and meta-analysis. 29(4). https://doi.org/10.1002/dmrr.2393
Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxel.
Lu, J., Huang, P.-L., Zhao, J., Chen, Q., Li, X., Gao, J., Venkataramanan, R., & Li, X. (2013). Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxel. 10(8). https://doi.org/10.1021/mp300729y
Pagination
- First page
- …
- 17
- 18
- 19
- …
- Last page